Is Late Luminal Loss an Accurate Predictor of the Clinical Effectiveness of Drug-Eluting Stents in the Coronary Arteries?
- 1 March 2006
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 97 (5), 603-605
- https://doi.org/10.1016/j.amjcard.2005.09.095
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Sirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary RevascularizationNew England Journal of Medicine, 2005
- Paclitaxel-Eluting or Sirolimus-Eluting Stents to Prevent Restenosis in Diabetic PatientsNew England Journal of Medicine, 2005
- Relationship between angiographic late loss and target lesion revascularization after coronary stent implantationJournal of the American College of Cardiology, 2005
- Relationship of Late Loss in Lumen Diameter to Coronary Restenosis in Sirolimus-Eluting StentsCirculation, 2005
- A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology: The TAXi trialJournal of the American College of Cardiology, 2005
- Sirolimus-Eluting Stent or Paclitaxel-Eluting Stent vs Balloon Angioplasty for Prevention of Recurrences in Patients With Coronary In-Stent RestenosisJAMA, 2005
- Comparison of Late Luminal Loss Response Pattern After Sirolimus-Eluting Stent Implantation or Conventional StentingCirculation, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS)The Lancet, 2003
- Bimodal Distribution of Angiographic Measures of Restenosis Six Months After Coronary Stent PlacementCirculation, 1997